Is Zomedica Corp (NYSE: ZOM) a good stock to buy now?
Zomedica Corp. (ZOM) experienced a downtrend of -12.88% in the last trade, closing at $0.21. At its current level, the...
FintechZoom > Articles by: James Albert
James Albert is a personal-finance analyst for FintechZoom and is based in New York. Contact: [email protected]
Zomedica Corp. (ZOM) experienced a downtrend of -12.88% in the last trade, closing at $0.21. At its current level, the...
Oil prices struck $120 a barrel on Monday after Saudi Arabia increased crude prices for July as well as amid...
CHASING NEW HORIZONSThe GMT-Master was made for airborne adventure. Now the watch of choice for travellers, it connects people beyond...
Marketing leaders are adept at marketing brands without being salesy. They’ve truly mastered the art of persuasion and selling without...
NEW YORK, May 26 (FintechZoom): This 26th of May the market staged a recovery on excellent news from retailers, which gave...
NEW YORK, May 26 (FintechZoom): Last trading session was dominated by EUR/USD - Euro US Dollar which signed 0.38% and...
NEW YORK, May 25 (FintechZoom): Markets continue their turbulence with the Dow closing higher on Wednesday after the FED showed...
LONDON, May 25 (FintechZoom): Stoxx 600 again up with the European market. The continental index brought all the market up...
NEW YORK, May 24 (FintechZoom): The Dow Jones industrial average closed up 50 points today, after suffering its biggest one-day...
NEW YORK, May 24 (FintechZoom): Last trading session was dominated by EUR/USD - Euro US Dollar which signed a 0.45%...